Drug-coating Balloon Angioplasties for True Coronary Bifurcation Lesions

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 784 participants.

Also called NCT04242134

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 784 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT04242134
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT04242134. Randomized; single masking; primary purpose treatment. Start 2020-09-08 (actual); primary completion 2024-06-27 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Drug-coating Balloon Angioplasties for True Coronary Bifurcation Lesions
Acronym
DCB-BIF
Intervention (Device)
Drug-coating balloon
Lead sponsor
Nanjing First Hospital, Nanjing Medical University (class: other)

Record details

Record id
cardio:ct-nct04242134
Content hash
33db7bf37e1188548f7d799d725b333ae5d9ba9aac4b0793c2fff886bbf990e9